A meta-analysis of caspase 9 polymorphisms in promoter and exon sequence on cancer susceptibility

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Xu, Wei ^a   Jiang, Shengqiang ^b   Xu, Yuanyuan ^a   Chen, Bo ^a   Li, Yan ^a   Zong, Feng ^a   Zhao, Weihong ^a   Wu, Jianqing ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b HOHAI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 9;

ALLELE; ARTICLE; ASIAN; CANCER RISK; CANCER SUSCEPTIBILITY; CASPASE 9 GENE; CAUCASIAN; ETHNIC DIFFERENCE; EXON; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; LUNG CANCER; MOLECULAR PATHOLOGY; PROMOTER REGION; PROSTATE CANCER; PROTECTION; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; LUNG TUMOR; MALE; META ANALYSIS; NEOPLASM;

ASIAN CONTINENTAL ANCESTRY GROUP; CASPASE 9; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXONS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASMS; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC;

EID: 84861205230     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037443     Document Type: Article

References (30)

1. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation. Cell 14: 646-74.
2. Olsson M, Zhivotovsky B, (2011) Caspases and cancer. Cell Death Differ 18: 1441-9.
3. Degterev A, Boyce M, Yuan J, (2003) A decade of caspases. Oncogene 22: 8543-67.
4. Adrain C, Martin SJ, (2001) The mitochondrial apoptosome: a killer unleashed by the cytochrome seas. Trends Biochem Sci 26: 390-7.
5. Allan LA, Clarke PR, (2009) Apoptosis and autophagy: Regulation of caspase-9 by phosphorylation. FEBS J 276: 6063-73.
6. Park JY, Park JM, Jang JS, Choi JE, Kim KM, et al. (2006) Caspase 9 promoter polymorphisms and risk of primary lung cancer. Hum Mol Genet 15: 1963-71.
7. Lou Y, Fang CQ, Li JH, (2007) A study on the expression of CASP9 gene and its polymorphism distribution in non-small cell lung cancer. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 24: 59-62.
8. Lee SY, Choi YY, Choi JE, Kim MJ, Kim JS, et al. (2010) Polymorphisms in the caspase genes and the risk of lung cancer. J Thorac Oncol 5: 1152-8.
9. Liu CY, Wu MC, Chen F, Ter-Minassian M, Asomaning K, et al. (2010) A Large-scale genetic association study of esophageal adenocarcinoma risk. Carcinogenesis 31: 1259-63.
10. Fang CQ, Liu SL, Lou Y, Li JH, (2007) Expression of the caspase 9 gene and its polymorphism distribution in gastric cancer. Shijie Huaren Xiaohua Zazhi 15: 3190-3.
11. Liamarkopoulos E, Gazouli M, Aravantinos G, Tzanakis N, Theodoropoulos G, et al. (2011) Caspase 8 and caspase 9 gene polymorphisms and susceptibility to gastric cancer. Gastric Cancer 14: 317-21.
12. He XM, Wang LL, Fang CQ, Liu SL, Lou Y, et al. (2008) Expression of CASP9 gene and its polymorphism distribution in colon cancer. Shijie Huaren Xiaohua Zazhi 16: 2371-5.
13. Theodoropoulos GE, Gazouli M, Vaiopoulou A, Leandrou M, Nikouli S, et al. (2011) Polymorphisms of Caspase 8 and Caspase 9 gene and colorectal cancer susceptibility and prognosis. Int J Colorectal Dis 26: 1113-8.
14. Wu H, (2009) Correlation between Caspase 9 single nucleotide polymorphism and susceptibility to hepatocellular carcinoma in Fusui county of Guangxi. PhD thesis. Guangxi Medical University, Doctoral Dissertation full-text database of China.
15. Theodoropoulos GE, Michalopoulos NV, Panoussopoulos SG, Taka S, Gazouli M, (2010) Effects of caspase-9 and survivin gene polymorphisms in pancreatic cancer risk and tumor characteristics. Pancreas 39: 976-80.
16. Kesarwani P, Mandal RK, Maheshwari R, Mittal RD, (2011) Influence of caspases 8 and 9 gene promoter polymorphism on prostate cancer susceptibility and early development of hormone refractory prostate cancer. BJU Int 107: 471-6.
17. George GP, Mandal RK, Kesarwani P, Sankhwar SN, Mandhani A, et al. (2011) Polymorphisms and haplotypes in caspases 8 and 9 genes and risk for prostate cancer: A case-control study in cohort of North India. Urol Oncol [Epub ahead of print].
18. Gangwar R, Mandhani A, Mittal RD, (2009) Caspase 9 and caspase 8 gene polymorphisms and susceptibility to bladder cancer in north Indian population. Ann Surg Oncol 16: 2028-34.
19. Wang YX, Zhao L, Wang XY, Liu CM, Yu SG, (2011) Role of Caspase 8, Caspase 9 and Bcl-2 polymorphisms in papillary thyroid carcinoma risk in Han Chinese population. Med Oncol [Epub ahead of print].
20. Lan Q, Zheng T, Chanock S, Zhang Y, Shen M, et al. (2007) Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma. Carcinogenesis 28: 823-7.
21. Hosgood HD 3rd, Baris D, Zhang Y, Zhu Y, Zheng T, et al. (2008) Caspase polymorphisms and genetic susceptibility to multiple myeloma. Hematol Oncol 26: 148-51.
22. Cochran WG, (1954) The combination of estimates from different experiments. Biometrics 10: 101-29.
23. Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-48.
24. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-88.
25. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-34.
26. Ghavami S, Hashemi M, Ande SR, Yeganeh B, Xiao W, et al. (2009) Apoptosis and cancer: mutations within caspase genes. J Med Genet 46: 497-510.
27. Yin M, Yan J, Wei S, Wei Q, (2010) CASP8 polymorphisms contribute to cancer susceptibility: evidence from a meta-analysis of 23 publications with 55 individual studies. Carcinogenesis 31: 850-7.
28. Grabe N, (2002) AliBaba2: context specific identification of transcription factor binding sites. In Silico Biol 2: S1-15.
29. Hirano A, Nagai H, Harada H, Haga S, Kajiwara T, et al. (2001) Two novel single-nucleotide polymorphisms of the Caspase-9 (CASP9) gene in the Japanese population. Genes Immun 2: 117-8.
30. Andreoli V, Trecroci F, La Russa A, Valentino P, Condino F, et al. (2009) CASP-9: A susceptibility locus for multiple sclerosis in Italy. J Neuroimmunol 210: 100-3.